New Ideas.
Better Results.

Blue Matter is a consulting firm serving the life sciences industry. We strive to bring a new approach to consulting with original ideas that deliver a meaningful impact.

Contact Us

Our Purpose

We are proud to be part of an industry that is pushing the boundaries of science and technology to improve people’s lives. Our role is to help our clients identify unique insights, generate new ideas and drive meaningful results to get the most out of their products, portfolios and teams.

We began our careers in established consulting firms where we developed valuable experience and industry knowledge. During this time, we came to see that rigid processes often interfered with original thinking and led to bloated deliverables packed with mediocre answers.

A group of us like-minded, passionate consultants believed there was a better approach and founded Blue Matter to provide a platform to foster innovation and creativity in consulting.

Our Difference

Industry and scientific knowledge, analysis and insights. Left brain thinking. This is the foundation of our discipline. Creativity and imagination. Constantly challenging conventional thinking and seeking fresh ideas. Right brain thinking. We’re passionate about this; it’s the reason our clients come back.

The key to winning is effective differentiation. And effective differentiation comes from originality–thinking that is grounded in reason and infused with imagination.

"The terrific work you did resulted in a substantial change to our commercial strategy."

- Chairman of the Board, Small Biotech

"Thank you very much for the great work and partnership. You are one of the rare breed of consultants whom I trust. You will always be on my speed dial if we need help with anything."

- Chief Commercial Officer, Small Biotech

"I appreciate all of the great work you have done for our team this past year and look forward to continued partnership in the New Year."

- Chief Commercial Officer, Mid-sized Diagnostic Company

"Your preparation and support has been instrumental in achieving our desired outcome."

- Franchise Commercial Lead, Global Biotech

"Thank you all so much for the extremely successful project...I couldn't be happier with the way that it went."

- Sr. Product Manager, Diagnostic Company

"This project was excellent, from the content development to facilitation. Many, many thanks for the great work!"

- Director of Marketing, Diagnostic Company

"The process was great, I loved that I didn't have to manage you that much. Everything was highly organized and done on time. Quality and originality of thinking was also good."

- Global Commercial Lead, Large Biotech

"Great project. I was learning as we went along; good expertise — brought in examples from other projects."

- Global Commercial Lead, Large Biotech

Our Clients

Our clients include: top global bio-pharmaceutical companies with large, diverse product portfolios to small emerging players with one asset in development, leading diagnostic companies, and investment houses. We work with CEOs, Chief Commercial Officers, Franchise Heads, Product Directors, Functional Area Leaders. 90%+ of our business is from repeat, satisfied customers.

Our Services

Shape Innovative Products

Drive Successful Launches

Build Great Portfolios and Companies

Pathfinder Capabilities

Blue Matter offers in-depth market expertise across North American and European markets.

Our Pathfinder offerings are specifically designed to help growing biopharma companies succeed in European markets.

Learn more: 7 Keys to Success in Europe

Want to Join Our Team?

Blue Matter offers enriching project experiences with a diverse range of strategic, client-facing projects in the exciting and innovative life sciences industry.

Join Our Team


NEW paper on how #biopharma companies can successfully enter Europe: #pharmaceutical #biotech #Europe #strategy

Emerging #biopharma companies: Building a team in Europe? Here are some things to keep in mind when recruiting & hi…

Blue Matter “Breakfast Club” Meeting #4: A Conversation with Dr. Thomas Lönngren, Former Exec. Dir. of the EMA

The Blue Matter Breakfast Club is an ongoing series of two-hour breakfast forums, hosted by our team in Europe.  These forums are by invitation, bringing together thought leaders and executives from biopharma companies and other organizations to discuss critical business issues. The fourth Breakfast Club meeting was a virtual event on 13th May 2020.  The guest … Read More

Continuing the Fight Against Lung Cancer with the GO2 Foundation for Lung Cancer

Last year, we wrote about our charitable work with a great non-profit organization, the Addario Lung Cancer Foundation (ALCF).  We’re proud to say that our work has continued with this organization.  However, things have changed over the past year, as the ALCF has merged with the Lung Cancer Alliance to form the GO2 Foundation for … Read More

The Science Won’t Sell Itself

“Plans are worthless, but planning is everything.” That well-known quote comes from Dwight D. Eisenhower, 34th president of the United States and former Supreme Commander of the Allied Expeditionary Force in Europe.  It’s a pithy quote—though perhaps a little overstated—that highlights the critical importance of planning for any serious undertaking. For a biopharmaceutical company, the … Read More

The Rarest of Them All: Why Neglected Rare Diseases Require a Very Different Mindset

Introduction In previous articles, we explored several important aspects of rare diseases (RDs).  First, we showed how different authorities define the term “rare disease” (or “orphan disease”).  We also established a spectrum of rarity, ranging from those diseases that are considered common—with well-established treatment paradigms—to those that are “hyper-orphan,” affecting perhaps a couple of people … Read More

The COVID-19 Challenge: How Pharma Can Adapt and Succeed in the Face of an Uncertain Future

Current Scenario: Challenges, Opportunities, and Critical Success Factors The current situation regarding COVID-19 is alarming.  At the time of publication, infection and death rates are continuing to rise rapidly in the United States, Spain, Switzerland, and many other European countries. In other countries like China, Italy, and Germany the situation appears to be resolving, but … Read More

How Rare Is Rare? Making Sense of Rare Disease Definitions, Nomenclature, and Patient Numbers

Many people working in and around the health care system and the biopharmaceutical industry use the terms “rare disease” and “orphan disease” on a fairly regular basis.  Obviously, they refer to any disease that’s uncommon, often with few treatment options (or no treatment options).  But what do these terms really mean? What’s the actual definition … Read More

Location, Location, Location: Why You Need a Systematic Approach to Locating Your European HQ

Location, Location, Location:  Most regard that as the first rule of real estate.  Simply put, it refers to the fact that a home’s value can vary dramatically based solely on its location.  Nice neighborhood with good schools, low crime, and beautiful tree-lined streets? In a place like that, a home will command a much higher … Read More